Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing partners ...
Figure 1: Overexpression of a 48-nt stem-loop structure in TLC1 interferes with telomeric silencing. Figure 2: Overexpression of the TLC1 48-nt stem-loop mimics a ykuΔ mutation. Figure 3: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results